Clinical Trial Update: Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A [Phase 2, Phase 3]

View source ↗

Summary

A pediatric pharmacokinetics and efficacy/safety study of recombinant Factor VIII (rAHF-PFM) in Hemophilia A has completed Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• recombinant Factor VIII (rAHF-PFM) (recombinant Factor VIII (rAHF-PFM))

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 2, Phase 3 | Status: COMPLETED